H
HCW Biologics
HCWB
0.62000
USD
-0.0217
(-3.38%)
مغلق
حجم التداول
3
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
16,642,293
العنوان: HCW Biologics
القطاع: Healthcare
الصناعة: Biotechnology
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.